サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1761099

遠隔監視システムの世界市場

Telemonitoring Systems

出版日
ページ情報
英文 186 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.41円
遠隔監視システムの世界市場
出版日: 2025年07月02日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

遠隔監視システムの世界市場は2030年までに45億米ドルに到達

2024年に27億米ドルと推定される遠隔監視システムの世界市場は、分析期間2024-2030年にCAGR 8.6%で成長し、2030年には45億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるCOPDモニタリングは、CAGR 8.1%を記録し、分析期間終了までに12億米ドルに達すると予測されます。血圧モニタリング分野の成長率は、分析期間でCAGR 9.2％と推定されます。

米国市場は7億530万米ドルと推定、中国はCAGR11.4％で成長予測

米国の遠隔監視システム市場は、2024年に7億530万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを11.4%として、2030年には予測市場規模9億8,670万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.7%と6.8%と予測されています。欧州では、ドイツがCAGR約6.4%で成長すると予測されています。

世界の遠隔監視システム市場- 主要動向と促進要因まとめ

遠隔監視システムとは何か、なぜヘルスケアにおいて重要なのか？

遠隔監視システムは、ヘルスケアプロバイダーがデジタル通信技術を使って患者のバイタルサイン、症状、健康状態全般を遠隔監視することを可能にします。これらのシステムは、慢性疾患の管理、急性期後のケア、高齢者ケアに不可欠であり、頻繁に病院を訪れることなく継続的なモニタリングを提供します。血圧、心拍数、グルコースレベル、酸素飽和度などのデータをリアルタイムで送信することにより、遠隔監視システムはヘルスケア専門家がタイムリーに介入し、治療計画を調整し、患者の転帰を改善することを可能にします。これは、高齢化が進み、糖尿病や心血管疾患などの慢性疾患が増加している状況においては特に重要なことであり、積極的なモニタリングは入院を減らし、医療費を管理する鍵となります。

遠隔監視システムはヘルスケアでどのように使われていますか？

遠隔監視システムは、病院、クリニック、在宅医療の現場で幅広く利用されており、患者と医療提供者の双方に柔軟性を提供しています。病院では、遠隔モニタリングはより広範な遠隔医療戦略に統合され、臨床医は術後や慢性疾患の治療中の患者の回復を追跡することができます。在宅ヘルスケアでは、遠隔モニタリングは患者が自分の健康を自己管理できるようにする一方、医師や看護師は患者のデータに遠隔アクセスして、情報に基づいた意思決定を行うことができます。これは、ヘルスケア施設へのアクセスが限られている地方では特に有益です。さらに、遠隔監視システムは、リハビリ中の患者の遠隔モニタリングや、頻繁な通院なしに継続的な監視を確保するための出産や小児ケアなど、専門的なケアにも採用されています。

遠隔監視システム市場の主要セグメントは？

主要コンポーネントには、デバイス（センサー、ウェアラブル、モバイルヘルスアプリなど）とサービス（データ収集、分析、リアルタイムレポートなど）が含まれます。アプリケーションは、慢性疾患管理、急性期後のケア、予防ケア、高齢者ケアに及ぶ。エンドユーザー別では、病院、在宅ケア環境、診療所が主な市場セグメントを形成しています。地域別では、北米が先進的なヘルスケア・インフラを背景に市場をリードしている一方、アジア太平洋は遠隔医療技術の採用増加や遠隔地でのヘルスケア・アクセスを改善するための政府の取り組みによって急成長を遂げています。新興市場もまた、ヘルスケアプロバイダーがインフラの課題に対処するために遠隔モニタリングを導入していることから、成長に寄与しています。

遠隔監視システム市場の成長は複数の要因によってもたらされる

遠隔監視システム市場の成長は、慢性疾患の有病率の上昇、高齢者人口の増加、ウェアラブル技術やワイヤレス技術の進歩など、いくつかの要因によって牽引されています。患者が自宅で病状を管理できる在宅ヘルスケアソリューションへの注目の高まりが、遠隔監視システムの需要を大きく押し上げています。さらに、北米や欧州などの地域では、遠隔医療に対する規制支援や償還政策が市場拡大に拍車をかけています。AIと機械学習が遠隔監視システムに統合されることで、予測分析機能がさらに強化され、より積極的なケアが可能になります。また、遅延を最小限に抑えてリアルタイムのデータ伝送を容易にする5G技術の急速な採用も、市場の成長を加速させると予想されます。

セグメント

エンドユース（COPDモニタリング、血圧モニタリング、グルコースモニタリング、心血管疾患モニタリング、その他のエンドユース）

調査対象企業の例（注目の26社）

  • Abbott Laboratories
  • Aerotel Medical Systems（19）Ltd.
  • Allscripts Healthcare Solutions, Inc.
  • BioTelemetry, Inc.
  • Biotronik SE & Co. KG
  • Dragerwerk AG & Co. KGaA
  • Dream Systems LLC.
  • eVisit, Inc.
  • General Electric Company
  • Honeywell Life Care Solutions
  • Huawei Technologies Co., Ltd.
  • InTouch Health
  • LifeWatch AG
  • McKesson Corporation
  • Medtronic, Inc.
  • Philips Healthcare USA

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中のドメイン専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP15163

Global Telemonitoring Systems Market to Reach US$4.5 Billion by 2030

The global market for Telemonitoring Systems estimated at US$2.7 Billion in the year 2024, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2024-2030. COPD Monitoring, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Blood Pressure Monitoring segment is estimated at 9.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$705.3 Million While China is Forecast to Grow at 11.4% CAGR

The Telemonitoring Systems market in the U.S. is estimated at US$705.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$986.7 Million by the year 2030 trailing a CAGR of 11.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Telemonitoring Systems Market - Key Trends and Drivers Summarized

What Are Telemonitoring Systems and Why Are They Critical in Healthcare?

Telemonitoring systems enable healthcare providers to remotely monitor patients’ vital signs, symptoms, and overall health conditions using digital communication technologies. These systems are essential for chronic disease management, post-acute care, and elderly care, providing continuous monitoring without the need for frequent hospital visits. By transmitting real-time data such as blood pressure, heart rate, glucose levels, and oxygen saturation, telemonitoring systems allow healthcare professionals to make timely interventions, adjust treatment plans, and improve patient outcomes. This is particularly vital in the context of an aging population and increasing incidences of chronic diseases such as diabetes and cardiovascular conditions, where proactive monitoring is key to reducing hospitalizations and managing healthcare costs.

How Are Telemonitoring Systems Being Used Across Healthcare Settings?

Telemonitoring systems are widely used in hospitals, clinics, and home healthcare settings, providing flexibility for both patients and providers. In hospital settings, telemonitoring is integrated into broader telehealth strategies, allowing clinicians to track the recovery of patients post-surgery or during treatment for chronic conditions. In home healthcare, telemonitoring empowers patients to self-manage their health, while doctors and nurses can access patient data remotely to make informed decisions. This is particularly beneficial in rural areas where access to healthcare facilities is limited. Additionally, telemonitoring systems are employed in specialized care, such as remote monitoring for patients undergoing rehabilitation, as well as for maternity and pediatric care to ensure continuous oversight without frequent hospital visits.

What Are the Key Segments in the Telemonitoring Systems Market?

Key components include devices (such as sensors, wearables, and mobile health apps) and services (such as data collection, analytics, and real-time reporting). Applications span chronic disease management, post-acute care, preventive care, and elderly care. In terms of end-use, hospitals, home care settings, and clinics form the primary market segments. Regionally, North America leads the market due to advanced healthcare infrastructure, while Asia-Pacific is witnessing rapid growth driven by increasing adoption of telehealth technologies and government initiatives to improve healthcare access in remote areas. Emerging markets are also contributing to growth as healthcare providers embrace telemonitoring to address infrastructure challenges.

The Growth in the Telemonitoring Systems Market Is Driven by Several Factors

The growth in the telemonitoring systems market is driven by several factors, including the rising prevalence of chronic diseases, the growing elderly population, and advancements in wearable and wireless technologies. The increasing focus on home healthcare solutions, which allow patients to manage their conditions from home, is significantly boosting the demand for telemonitoring systems. Additionally, regulatory support for telehealth and reimbursement policies in regions like North America and Europe are fueling market expansion. The integration of AI and machine learning into telemonitoring systems is further enhancing predictive analytics capabilities, enabling more proactive care. The rapid adoption of 5G technology, which facilitates real-time data transmission with minimal latency, is also expected to accelerate market growth.

SCOPE OF STUDY:

The report analyzes the Telemonitoring Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 26 Featured) -

  • Abbott Laboratories
  • Aerotel Medical Systems (19) Ltd.
  • Allscripts Healthcare Solutions, Inc.
  • BioTelemetry, Inc.
  • Biotronik SE & Co. KG
  • Dragerwerk AG & Co. KGaA
  • Dream Systems LLC.
  • eVisit, Inc.
  • General Electric Company
  • Honeywell Life Care Solutions
  • Huawei Technologies Co., Ltd.
  • InTouch Health
  • LifeWatch AG
  • McKesson Corporation
  • Medtronic, Inc.
  • Philips Healthcare USA

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Telemonitoring Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Drives Adoption of Telemonitoring Systems
    • Rising Demand for Remote Patient Monitoring Strengthens Business Case for Telemonitoring
    • Growth of the Elderly Population Spurs Demand for Telemonitoring Solutions
    • Advancements in Wireless and Wearable Technologies Propel Growth in Telemonitoring
    • Expanding Use of Telemonitoring in Post-Acute Care Accelerates Market Expansion
    • Rising Healthcare Costs Drive Adoption of Cost-Effective Remote Monitoring Systems
    • Integration of AI and Machine Learning in Telemonitoring Systems Enhances Market Growth
    • Increased Focus on Home Healthcare Solutions Spurs Demand for Telemonitoring
    • Growing Use of Telemonitoring for Managing Diabetes and Cardiovascular Diseases Propels Market
    • Shift Toward Value-Based Care Strengthens Demand for Remote Monitoring Solutions
    • Emergence of 5G Technology Accelerates Adoption of Real-Time Telemonitoring
    • COVID-19 Pandemic Throws the Spotlight on Remote Monitoring and Telehealth Solutions
    • Rising Demand for Real-Time Data Analytics and Predictive Insights in Healthcare Sustains Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Telemonitoring Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Telemonitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for COPD Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for COPD Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for COPD Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Blood Pressure Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Blood Pressure Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Blood Pressure Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Glucose Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Glucose Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Glucose Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cardiovascular Disease Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Cardiovascular Disease Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Japan 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: China 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Telemonitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: France 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Germany 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Italy 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: UK 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 50: Spain Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Spain Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Spain 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 53: Russia Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Russia Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Russia 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Rest of Europe 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Telemonitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Asia-Pacific 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 65: Australia Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Australia Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Australia 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 68: India Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: India Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: India 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 71: South Korea Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: South Korea Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: South Korea 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Asia-Pacific Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Rest of Asia-Pacific 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Telemonitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Latin America 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 83: Argentina Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Argentina Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Argentina 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 86: Brazil Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Brazil Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Brazil 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 89: Mexico Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Mexico Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Mexico 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Latin America Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Latin America 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Telemonitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Middle East 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 101: Iran Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Iran Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Iran 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 104: Israel Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Israel Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Israel 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Saudi Arabia Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Saudi Arabia 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 110: UAE Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UAE Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UAE 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Middle East Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Middle East 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 116: Africa Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Africa Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Africa 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION